Publications by authors named "Daniel Escuin"

Claim this Profile
S
Small Non-Coding RNAs and Their Role in Locoregional Metastasis and Outcomes in Early-Stage Breast Cancer Patients.
Daniel Escuin, Olga Bell, Bárbara García-Valdecasas, Montserrat Clos, Itziar Larrañaga

Int J Mol Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating miRNA Expression Is Inversely Correlated with Tumor Tissue or Sentinel Lymph Nodes in Estrogen Receptor-Positive Early Breast Cancer Patients.
Daniel Escuin, Laura López-Vilaró, Olga Bell, Josefina Mora, Bárbara García-Valdecasas

Int J Mol Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating microRNAs in Early Breast Cancer Patients and Its Association With Lymph Node Metastases.
Daniel Escuin, Laura López-Vilaró, Josefina Mora, Olga Bell, Antonio Moral

Front Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-1291 Is Associated With Locoregional Metastases in Patients With Early-Stage Breast Cancer.
Daniel Escuin, Laura López-Vilaró, Olga Bell, Josefina Mora, Antonio Moral

Front Genet· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumor cholesteryl ester accumulation is associated with human breast cancer proliferation and aggressive potential: a molecular and clinicopathological study.
David de Gonzalo-Calvo, Laura López-Vilaró, Laura Nasarre, Maitane Perez-Olabarria, Tania Vázquez, Daniel Escuin

BMC Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromosome 17 centromere duplication and responsiveness to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Ariadna Tibau, Laura López-Vilaró, Maitane Pérez-Olabarria, Tania Vázquez, Cristina Pons, Daniel Escuin

Neoplasia· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic up-regulation and overexpression of PLEKHA7 differentiates invasive lobular carcinomas from invasive ductal carcinomas.
Bàrbara Castellana, Daniel Escuin, Maitane Pérez-Olabarria, Tania Vázquez, Josefina Muñoz

Hum Pathol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASPN and GJB2 Are Implicated in the Mechanisms of Invasion of Ductal Breast Carcinomas.
Bàrbara Castellana, Daniel Escuin, Gloria Peiró, Bárbara Garcia-Valdecasas, Tania Vázquez

J Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microtubules regulate hypoxia-inducible factor-1α protein trafficking and activity: implications for taxane therapy.
Marisa Carbonaro, Daniel Escuin, Aurora O'Brate, Maria Thadani-Mulero, Paraskevi Giannakakou

J Biol Chem· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-density lipoprotein receptor-related protein 1 is associated with proliferation and invasiveness in Her-2/neu and triple-negative breast carcinomas.
Lluis Catasus, Alberto Gallardo, Vicenta Llorente-Cortes, Daniel Escuin, Josefina Muñoz

Hum Pathol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignancies.
John Kauh, Chantal Chanel-Vos, Daniel Escuin, Michael P Fanucchi, R Donald Harvey

Cancer· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer.
Medha S Darshan, Matthew S Loftus, Maria Thadani-Mulero, Benjamin P Levy, Daniel Escuin

Cancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes.
Arun Kanakkanthara, Anja Wilmes, Aurora O'Brate, Daniel Escuin, Ariane Chan

Mol Cancer Ther· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort?
Núria Montserrat, Alberto Gallardo, Daniel Escuin, Lluís Catasus, Jaime Prat

Hum Pathol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hematopoietic-specific beta1-tubulin is naturally resistant to 2-methoxyestradiol and protects patients from drug-induced myelosuppression.
Daniel Escuin, Patricia A Burke, Grainne McMahon-Tobin, Todd Hembrough, Yuefang Wang

Cell Cycle· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model.
Seung-Hee Kang, Heidi T Cho, Sarojini Devi, Zhaobin Zhang, Daniel Escuin

Cancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function.
Daniel Escuin, Erik R Kline, Paraskevi Giannakakou

Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
beta-Tubulin mutations are associated with resistance to 2-methoxyestradiol in MDA-MB-435 cancer cells.
Yesim Gökmen-Polar, Daniel Escuin, Chad D Walls, Sharon E Soule, Yuefang Wang

Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploitation of the HIF axis for cancer therapy.
Daniel Escuin, Jonathan W Simons, Paraskevi Giannakakou

Cancer Biol Ther· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients.
Jose Luis Ramirez, Carme Sarries, Pedro Lopez de Castro, Barbara Roig, Cristina Queralt, Daniel Escuin

Cancer Lett· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.
Nicola J Mabjeesh, Daniel Escuin, Theresa M LaVallee, Victor S Pribluda, Glenn M Swartz

Cancer Cell· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis